Community Regional Medical Center, Department of Pharmacy Services, P.O. Box 1232, Fresno, CA 93715, United States of America; California Health Sciences University (CHSU), College of Osteopathic Medicine, 2500 Alluvial Ave, Clovis, CA 93611, United States of America; University of California San Francisco at Fresno, Department of Emergency Medicine, 155 N Fresno St, Fresno, CA 93701, United States of America.
California Health Sciences University (CHSU), College of Osteopathic Medicine, 2500 Alluvial Ave, Clovis, CA 93611, United States of America.
Am J Emerg Med. 2024 Oct;84:120-123. doi: 10.1016/j.ajem.2024.07.061. Epub 2024 Aug 3.
Current protocols which include the administration of a single dextrose dose concomitantly with insulin are inadequate as hypoglycemia commonly occurs 60 min after insulin administration and may persist for up to two hours post-insulin administration. To prevent delayed hypoglycemic events, our institution revised our adult acute hyperkalemia order set to include hypoglycemic preventative measures not currently described in the literature.
The primary purpose of this retrospective study was to determine if the new adult acute hyperkalemia order set resulted in lower rates of hypoglycemia (glucose <70 mg/dL) compared to the old order set in patients with impaired renal clearance and lower pre-insulin glucose values. In addition to reducing the IV regular insulin dose from 10 to 5 units, the new order set recommends patients receive a 250 mL dextrose 10% solution over two hours in addition to a 50 mL dextrose 50% IV push concomitantly with IV regular insulin if their pre-insulin glucose is ≤250 mg/dL. Patients were included if they were adults, received IV regular insulin from the order set within six hours of presenting to the ED, had a pre-insulin potassium >5.5 mmol/L, had a pre-insulin glucose ≤250 mg/dL, and had impaired renal clearance [creatinine clearance (CrCl) < 30 mL/min or dialysis dependent].
100 patients were included in each arm. The median pre-insulin potassium levels were 6.4 mmol/L and 6.3 mmol/L in the old and new groups, respectively (p = 0.133). The median pre-insulin glucose levels were 120 mg/dL and 107.5 mg/dL in the old and new groups, respectively (p = 0.013). Twenty (20%) patients in the old group developed hypoglycemia, whereas six (6%) patients in the new group developed hypoglycemia (p = 0.003). There was no significant difference between the two groups in number of patients who achieved a post-insulin potassium level ≤ 5.5 mmol/L.
Our study found that our approach of additionally administering a 250 mL dextrose 10% solution upon therapy initiation is associated with significantly lower rates of hypoglycemia. Our findings indicate that hypoglycemia rates can be significantly reduced in vulnerable populations if additional preventative measures are employed.
目前的方案包括同时给予单剂量葡萄糖和胰岛素,但由于胰岛素给药后 60 分钟常发生低血糖,且可能持续至胰岛素给药后两小时,因此这些方案并不充分。为了预防延迟性低血糖事件,我们机构修订了成人急性高钾血症医嘱集,纳入了目前文献中未描述的预防低血糖措施。
本回顾性研究的主要目的是确定与旧医嘱集相比,新的成人急性高钾血症医嘱集是否会降低肾清除功能受损和胰岛素给药前血糖值较低的患者的低血糖(血糖<70mg/dL)发生率。除了将静脉普通胰岛素剂量从 10 单位降至 5 单位外,如果患者胰岛素给药前血糖≤250mg/dL,新医嘱集还建议患者在 2 小时内输注 250mL 10%葡萄糖溶液,并同时给予 50mL 50%葡萄糖静脉推注。如果患者符合以下条件,则纳入研究:成人、在急诊科就诊后 6 小时内使用医嘱集中的静脉普通胰岛素、胰岛素给药前血钾>5.5mmol/L、胰岛素给药前血糖≤250mg/dL 且肾清除功能受损[肌酐清除率(CrCl)<30mL/min 或依赖透析]。
每组各纳入 100 例患者。旧组和新组的胰岛素给药前血钾中位数分别为 6.4mmol/L 和 6.3mmol/L(p=0.133)。旧组和新组的胰岛素给药前血糖中位数分别为 120mg/dL 和 107.5mg/dL(p=0.013)。旧组有 20 例(20%)患者发生低血糖,而新组有 6 例(6%)患者发生低血糖(p=0.003)。两组患者中胰岛素给药后血钾水平≤5.5mmol/L 的患者比例无显著差异。
本研究发现,我们在起始治疗时额外给予 250mL 10%葡萄糖溶液的方法与低血糖发生率显著降低相关。我们的研究结果表明,如果采取额外的预防措施,脆弱人群的低血糖发生率可显著降低。